Nanoviricides, Inc.
NNVC- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001379006
No open-market purchases or sales by Nanoviricides, Inc. insiders were filed in the last 90 days; 47 institutions reported holding it in 13F filings for Q2 2026, worth $3.27M in total; no superinvestor holds it.
Q4 2021 vs. Q3 2021
How the institutions holding Nanoviricides, Inc. changed between Q3 2021 and Q4 2021.
All holders in Q4 2021All holders in Q3 2021
| Measure | Q3 2021 | Q4 2021 | Change |
|---|---|---|---|
| Holders | 33 | 29 | −4 |
| Shares | 957.8K | 1.11M | +151.8K (+15.8%) |
| Value | $4.44M | $4.13M | −$313.9K (−7.1%) |
New holders (5)
Institutions that held Nanoviricides, Inc. at the end of Q4 2021 but not at the end of Q3 2021.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Renaissance Technologies LLC | 44,600 | $166.0K | 0.00% |
| Wharton Business Group, LLC | 17,236 | $64.0K | 0.00% |
| Citadel Advisors LLC | 13,615 | $51.0K | 0.00% |
| Simplex Trading, LLC | 6,287 | $23.0K | 0.00% |
| TD Waterhouse Canada Inc. | 429 | $1.88K | 0.00% |
Sold out (9)
Institutions that held Nanoviricides, Inc. at the end of Q3 2021 and filed for Q4 2021 without it.
| Institution | Shares, Q3 2021 | Value, Q3 2021 |
|---|---|---|
| Susquehanna International Group, LLP | 28,432 | $132.0K |
| Jane Street Group, LLC | 21,212 | $98.0K |
| Virtu Financial LLC | 19,793 | $92.0K |
| Marshall Wace, LLP | 11,037 | $51.0K |
| Tower Research Capital LLC (TRC) | 2,767 | $13.0K |
| Brewin Dolphin Ltd | 8 | $37 |
| Harbour Investments, Inc. | 35 | $0 |
| Belvedere Trading LLC | 28 | $0 |
| Walled Lake Planning & Wealth Management, LLC | 50 | $0 |